4th Quarter - Report

TIBER CREEK GROUP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the FDA STATES Act (S. 3032), and Health and Human Services pertaining to CBD policies.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3032 (116th)

Budget/Appropriations BUD

Appropriations issues related to the FDA CBD products, HHS pertaining to CBD policy.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to the FDA and the STATES Act (S. 3032), HHS pertaining to CBD policy.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
EMILY KIRLIN —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3032 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.